Going against the tide--how encephalitogenic T cells breach the blood-brain barrier
- PMID: 22948545
- DOI: 10.1159/000341232
Going against the tide--how encephalitogenic T cells breach the blood-brain barrier
Abstract
During multiple sclerosis or its animal model, experimental autoimmune encephalomyelitis, circulating immune cells enter the central nervous system (CNS) causing neuroinflammation. Extravasation from the blood circulation across the vessel wall occurs through a multistep process regulated by adhesion and signal transducing molecules on the immune cells and on the endothelium. Since the CNS is shielded by the highly specialized blood-brain barrier (BBB), immune cell extravasation into the CNS requires breaching this particularly tight endothelial border. Consequently, travelling into the CNS demands unique adaptations which account for the extreme tightness of the BBB. Modern imaging tools have shown that after arresting on BBB endothelium, in vivo or in vitro encephalitogenic effector/memory T cells crawl for long distances, possibly exceeding 150 µm along the surface of the BBB endothelium before rapidly crossing the BBB. Interestingly, in addition to the distance of crawling, the preferred direction of crawling against the flow is unique for T cell crawling on the luminal surface of CNS microvessels. In this review, we will summarize the cellular and molecular mechanisms involved in the unique T cell behavior that is obviously required for finding a site permissive for diapedesis across the unique vascular bed of the BBB.
Copyright © 2012 S. Karger AG, Basel.
Similar articles
-
Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier.Eur J Immunol. 2015 Apr;45(4):1043-58. doi: 10.1002/eji.201445125. Epub 2015 Jan 23. Eur J Immunol. 2015. PMID: 25545837
-
T-cell trafficking competence is required for CNS invasion.J Neuroimmunol. 2006 Aug;177(1-2):1-10. doi: 10.1016/j.jneuroim.2006.05.024. Epub 2006 Jul 5. J Neuroimmunol. 2006. PMID: 16822552
-
Differential roles for endothelial ICAM-1, ICAM-2, and VCAM-1 in shear-resistant T cell arrest, polarization, and directed crawling on blood-brain barrier endothelium.J Immunol. 2010 Oct 15;185(8):4846-55. doi: 10.4049/jimmunol.0903732. Epub 2010 Sep 22. J Immunol. 2010. PMID: 20861356
-
Capture, crawl, cross: the T cell code to breach the blood-brain barriers.Trends Immunol. 2012 Dec;33(12):579-89. doi: 10.1016/j.it.2012.07.004. Epub 2012 Aug 25. Trends Immunol. 2012. PMID: 22926201 Review.
-
Molecular mechanisms involved in T cell migration across the blood-brain barrier.J Neural Transm (Vienna). 2006 Apr;113(4):477-85. doi: 10.1007/s00702-005-0409-y. J Neural Transm (Vienna). 2006. PMID: 16550326 Review.
Cited by
-
Brain capillary obstruction during neurotoxicity in a mouse model of anti-CD19 chimeric antigen receptor T-cell therapy.Brain Commun. 2021 Dec 31;4(1):fcab309. doi: 10.1093/braincomms/fcab309. eCollection 2022. Brain Commun. 2021. PMID: 35169706 Free PMC article.
-
Partial rescue of mucopolysaccharidosis type VII mice with a lifelong engraftment of allogeneic stem cells in utero.Congenit Anom (Kyoto). 2015 Feb;55(1):55-64. doi: 10.1111/cga.12099. Congenit Anom (Kyoto). 2015. PMID: 25421592 Free PMC article.
-
The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy.Int J Mol Sci. 2020 Oct 5;21(19):7358. doi: 10.3390/ijms21197358. Int J Mol Sci. 2020. PMID: 33027976 Free PMC article. Review.
-
A novel preclinical method to quantitatively evaluate early-stage metastatic events at the murine blood-brain barrier.Cancer Prev Res (Phila). 2015 Jan;8(1):68-76. doi: 10.1158/1940-6207.CAPR-14-0225. Epub 2014 Oct 27. Cancer Prev Res (Phila). 2015. PMID: 25348853 Free PMC article.
-
Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.Curr Pharm Des. 2016;22(9):1177-1193. doi: 10.2174/1381612822666151221150733. Curr Pharm Des. 2016. PMID: 26685681 Free PMC article. Review.